Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: Preliminary clinical experience

Critical Reviews in Oncology/Hematology

Volumn 47, Issue 2, 2003, Pages 127-139

  Colombo, Renzo ^a   Salonia, A ^a   Da Pozzo, L F ^a   Naspro, R ^a   Freschi, M ^a   Paroni, R ^a   Pavone Macaluso, M ^b   Rigatti, P ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Bladder cancer; Chemotherapy; Local hyperthermia

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYTOSTATIC AGENT; MITOMYCIN C; MITOXANTRONE; THIOTEPA;

BLADDER CANCER; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; CYSTITIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG URINE LEVEL; DYSURIA; FOLLOW UP; HEMATURIA; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; IMMUNOPROPHYLAXIS; LABORATORY TEST; MULTIMODALITY CANCER THERAPY; NECROSIS; NOCTURIA; NONHUMAN; PAIN; PREVALENCE; PROPHYLAXIS; RASH; REVIEW; SUPERFICIAL CANCER; TEMPERATURE SENSITIVITY; TREATMENT INDICATION; TREATMENT OUTCOME; URETHRA STRICTURE; URETHRAL BLEEDING; URETHRAL PAIN; URINARY URGENCY;

EID: 0041666597     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(03)00076-3     Document Type: Review

References (40)

1. Jensen O.M., Estève J., et al. Cancer in the European community and its member states. Eur. J. Cancer. 26:1990;1167-1256.
2. Black R.J., Bray F., et al. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur. J. Cancer. 33:1997;1075-1107.
3. Torti F.M., Lum D.L., Aston D. Superficial bladder cancer: the primacy of grade in the development of invasive disease. J. Clin. Oncol. 5:(1):1987;125-130.
4. Soloway M.S., Murphy W.M., Johnson D.E., et al. Initial evaluation and response criteria for patients with superficial bladder cancer. Br. J. Urol. 66:1990;380-385.
5. Herr H.W., Laudone W.P., Withmore W.F. Jr. An overview of intravesical therapy for superficial blòadder tumors. J. Urol. 138:1987;1363-1368.
6. Lum B.L., Torti F.M. Adjuvant intravesicular pharmacotherapy for superficial bladder cancer. J. Natl. Cancer Inst. 83:1991;682-694.
7. Soloway M.S. The management of superficial bladder cancer. Cancer. 45:(Suppl.):1980;1856-1858.
8. Huland H., Otto U., Droese M., Kloppel G. Long term Mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival. J. Urol. 132:1994;27-29.
9. Lamm D.L. Long term results of intravesical therapy for superficial bladder cancer. Am. Urol. Clin. North Am. 19:1994;573-577.
10. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: progression and recurrence. J. Urol. 130:1983;108-1083.
11. Herr H.W. Intravesical therapy. A critical review. Urol. Clin. North Am. 14:1987;399-404.
12. Busch W. Uber den Einfluss, welchen heitigere Erysipeln zuweilen auf organisierte neubildungen ausuben. Verhandl Naturh. 1866;23-28 Preuss Rhein, Westphal.
13. Coley W.R. The treatment of malignant tumors by repeated inocluation of erysipelas. With a report of ten original cases. Am. J. Sci. 105:1893;487-489.
14. Herman T.S., Teicher B.A., Jochelson M., et al. Rationale for the use of local hyperthermia with radiation therapy and selected anticancer drug in locally advanced human malignancies. Int. J. Hyperthermia. 4:1988;143-158.
15. Millaer R.C., Richards M., Baird C., et al. Interaction of hyperthermia and chemotherapy agents: cell lethality and oncogenic potential. Int. J. Hyperthermia. 10:1994;89-99.
16. Oleson J.R., Calderwood S.K., Coughlin C.T., et al. Biological and clinical aspects of hyperthermia in cancer therapy. Am. J. Clin. Oncol. 11:(3):1988;368-380.
17. England H.R., Anderson J.D., Minasian H., et al. The therapeutic application of hyperthermia in the bladder. Br. J. Urol. 47:1976;849-852.
18. Le V.H., Wapnick P.V., et al. Tumor eradication by radiofrequency therapy. Response in 21 patients. J. Am. Med. Assoc. 235:1976;2198-2200.
19. Debicki P., Okoniewska E., Oboniewski M. Superficial and intraurethral applicators for microwave hyperthermia. Adv. Exp. Med. Biol. 267:1990;321-326.
20. Yerushalmi A., Fishelovitz Y., Singer D., et al. Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J. Urol. 133:1985;873-878.
21. Moffat F.L., Gilas T., Calhoun K., et al. Further experience with regional radiofrequency hyperthermia and cytotoxic chemotherapy for unresectable hepatic neoplasia. Cancer. 55:1985;1291-1295.
22. Chou C.K., Chen G.W., Guy A.W., Luk K.H. Formula for preparing phantom muscle tissue at various radiofrequencies. Bioelectromagnetics. 5:1984;435-441.
23. Rigatti P., Lev A., Da Pozzo L.F., Salonia A., Colombo R. Locally induced hyperthermia in bladder cancer. Syrigos K.N., Skinner D.G. Bladder cancer. Biology, diagnosis and management. 1999;393-406 Oxford Medical Pubblications.
24. Colombo R., Lev A., Da Pozzo L.F., et al. A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. J. Urol. 153:(3 Pt. 2):1995;959-963.
25. Rigatti P., Lev A., Colombo R. Combined intravesical chemotherapy with Mitomycin C and local bladder microwave-induced hyperthermia as a preoperative therapy for superficial bladder tumors. Eur. Urol. 20:1991;204-210.
26. Mauroy B., Bonnal J.L., Prevost B., et al. Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder. Prog. Urol. 9:(1):1999;69-80.
27. Matzkin H., Rangel M.C., Soloway M. In vitro study of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell lines. J. Urol. 147:1992;1671-1674.
28. Teicher B.A., Kawal C.D., Kennedy K.A., et al. Enhancement by hyperthermia in the in vitro cytotoxicity of Mitomycin C toward hypoxic tumoral cells. Cancer Res. 41:1981;1096-1112.
29. Wallner K., Banda M., et al. Hyperthermic enhancement of cell killing by Mitomycin C in Chinese hamster ovary cell. Cancer Res. 47:1987;1308-1312.
30. Sugimachi K., Inokuchi K., Kai H., et al. Preoperative hyperthermo-chemo-radiotherapy effective for carcinoma of the esophagous. Cancer Res. 27:1984;199-204.
31. Sthelin J.S., giovenella B.C., De Ipolyi P.D., et al. Results of 11 years experience with heated perfusion for melanoma of the extremities. Cancer Res. 39:1979;2255-2257.
32. Colombo R., Da Pozzo L.F., Lev A., et al. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J. Urol. 155:1996;1227-1232.
33. Colombo R., Da Pozzo L.F., Lev A., et al. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. J. Urol. 159:1998;783-787.
34. Colombo R, Da Pozzo LF, Salonia A, et al. Comparative study of intravesical chemotherapy alone versus intravesical thermo-chemotherapy for prophylaxis of recurrence of superficial transitional cell carcinoma. A multicentric study, J Clin Oncol, in press.
35. Paroni R., Salonia A., Lev A., et al. Effect of local hyperthermia of the bladder on Mytomicin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br. J. Pharmacol. 52:2001;278-279.
36. Paroni R., Arcelloni C., De Vecchi E., Fermo I., Mauri D., Colombo R. Plasma Mitomycin C concentrations determined by HPLC coupled to solid-phase extraction. Clin. Chem. 43:1997;615-618.
37. Song C.W., Kang M.S., Rhee J.G., et al. Th effect of hyperthermia on vacular function, pH and cell survival. Radiology. 137:1980;795-803.
38. Meyer J.L. The clinical efficacy of localized hyperthermia. Cancer Res. 44:(Suppl. 10):1984;4745s-4751s.
39. Hall R.R., Wadehra V., Towler J.M., et al. Hyperthermia in the treatment of bladder tumors. Br. J. Urol. 48:1976;603-608.
40. Ludgate C.M., McLean N., Carswell G.F., et al. Hyperthermic perfusion of the distended urinary bladder in the management of recurrent transitional cell carcinoma. Br. J. Urol. 47:1975;841-848.